State Board of Administration of Florida Retirement System Acquires 7,845 Shares of GE HealthCare Technologies Inc. $GEHC

State Board of Administration of Florida Retirement System boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.9% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 422,950 shares of the company’s stock after buying an additional 7,845 shares during the quarter. State Board of Administration of Florida Retirement System owned approximately 0.09% of GE HealthCare Technologies worth $31,328,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Allianz SE increased its holdings in GE HealthCare Technologies by 165.2% in the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. purchased a new position in GE HealthCare Technologies during the 2nd quarter valued at about $34,000. Game Plan Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 295.3% during the second quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after buying an additional 375 shares during the period. Zions Bancorporation National Association UT purchased a new stake in shares of GE HealthCare Technologies in the first quarter worth about $42,000. Finally, HFM Investment Advisors LLC bought a new position in shares of GE HealthCare Technologies in the first quarter valued at approximately $60,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC opened at $79.99 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The stock’s 50 day moving average price is $75.08 and its 200-day moving average price is $74.16. The stock has a market capitalization of $36.43 billion, a PE ratio of 16.53, a price-to-earnings-growth ratio of 3.34 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on GEHC. Citigroup lowered shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and reduced their price target for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Stifel Nicolaus set a $90.00 target price on GE HealthCare Technologies in a research note on Friday, November 21st. Morgan Stanley raised their price target on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a report on Thursday, October 30th. Finally, BTIG Research reissued a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a report on Friday, November 21st. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $86.45.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.